Cargando…

Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19

Background: In healthy pregnancies, components of the Renin-Angiotensin system (RAS) are present in the placental villi and contribute to invasion, migration, and angiogenesis. At the same time, soluble fms-like tyrosine kinase 1 (sFlt-1) production is induced after binding of ANG-II to its receptor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espino-y-Sosa, Salvador, Martinez-Portilla, Raigam Jafet, Torres-Torres, Johnatan, Solis-Paredes, Juan Mario, Estrada-Gutierrez, Guadalupe, Hernandez-Pacheco, Jose Antonio, Espejel-Nuñez, Aurora, Mateu-Rogell, Paloma, Juarez-Reyes, Angeles, Lopez-Ceh, Francisco Eduardo, Villafan-Bernal, Jose Rafael, Rojas-Zepeda, Lourdes, Guzman-Guzman, Iris Paola, Poon, Liona C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538263/ https://www.ncbi.nlm.nih.gov/pubmed/34696336 http://dx.doi.org/10.3390/v13101906

Ejemplares similares

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia—Systematic Review and Metanalysis
por: Marrufo-Gallegos, Karla Cecilia, et al.
Publicado: (2023)

sFlt-1 Is an Independent Predictor of Adverse Maternal Outcomes in Women With SARS-CoV-2 Infection and Hypertensive Disorders of Pregnancy
por: Hernandez-Pacheco, Jose Antonio, et al.
Publicado: (2022)

Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
por: Torres-Torres, Johnatan, et al.
Publicado: (2023)

Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: analysis of the Mexican National Surveillance Program
por: Martinez-Portilla, Raigam Jafet, et al.
Publicado: (2021)

Inflammatory-Metal Profile as a Hallmark for COVID-19 Severity During Pregnancy
por: Vásquez-Procopio, Johana, et al.
Publicado: (2022)

Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis
por: Dumnicka, Paulina, et al.
Publicado: (2016)

Maternal Death by COVID-19 Associated with Elevated Troponin T Levels
por: Torres-Torres, Johnatan, et al.
Publicado: (2022)

Plasma Total Antioxidant Capacity and Carbonylated Proteins Are Increased in Pregnant Women with Severe COVID-19
por: Solis-Paredes, Juan Mario, et al.
Publicado: (2022)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Serum Concentrations of Angiopoietin-2 and Soluble fms-Like Tyrosine Kinase 1 (sFlt-1) Are Associated with Coagulopathy among Patients with Acute Pancreatitis
por: Dumnicka, Paulina, et al.
Publicado: (2017)

Osteocalcin serum concentrations and markers of energetic metabolism in pediatric patients. Systematic review and metanalysis
por: Rodríguez-Narciso, Silvia, et al.
Publicado: (2023)

Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
por: Powers, Robert W., et al.
Publicado: (2010)

Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway
por: Gu, Ying, et al.
Publicado: (2017)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
por: Hannan, Natalie J., et al.
Publicado: (2017)

Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model
por: Vogtmann, Rebekka, et al.
Publicado: (2021)

Vertical transmission of coronavirus disease 2019
por: Martinez-Portilla, Raigam Jafet
Publicado: (2021)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

Maternal and Perinatal Outcomes Associated With Extremely High Values for the sFlt‐1 (Soluble fms‐Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio
por: Villalaín, Cecilia, et al.
Publicado: (2020)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

sFlt-1 in Chronic Kidney Disease: Friend or Foe?
por: Matsui, Masaru, et al.
Publicado: (2022)

Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study
por: Anton, Lauren, et al.
Publicado: (2010)

Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
por: Mayer-Pickel, Karoline, et al.
Publicado: (2019)

Long-term observational study of renal outcome after preeclampsia: Role of soluble fms-like tyrosine kinase-1(sFlt-1)/ placental growth factor (PlGF) and endoglin
por: Thitivichienlert, Thanaphan, et al.
Publicado: (2022)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
por: Chang, Xinwen, et al.
Publicado: (2023)

VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Prenatal Exome Sequencing in Recurrent Fetal Structural Anomalies: Systematic Review and Meta-Analysis
por: Pauta, Montse, et al.
Publicado: (2021)

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia
por: Bian, Xuming, et al.
Publicado: (2019)

Longitudinal circulating placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1) concentrations during pregnancy in Asian women: a prospective cohort study
por: Ng, Qiu Ju, et al.
Publicado: (2019)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
por: Kifle, Meron M., et al.
Publicado: (2022)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
por: Hussein, Sama, et al.
Publicado: (2022)

Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
por: Ku, Ching-Hsin, et al.
Publicado: (2008)

sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo
por: Altiok, Eda I., et al.
Publicado: (2016)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
por: Moore, Kyle H., et al.
Publicado: (2020)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

A simple detection method for the serum sFLT1 protein in preeclampsia
por: Shibuya, Masabumi, et al.
Publicado: (2021)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
por: Wang, Na, et al.
Publicado: (2021)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0t5iqkl8afe727gbcfrluhn3fv